Baker Jeffery Bradford sold $442K of PAYS

Baker Jeffery Bradford (Chief Financial Officer) sold 35,000 shares of Paysign, Inc. (PAYS) at $12.62 ($0.44M total) on 2026-08-12.

Original reporting
SEC EDGAR · Baker Jeffery Bradford
Published Aug 14, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PAYS
Neutral
medium confidence
Mentioned
$PAYS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PAYSNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale of 35,000 shares at $12.6182 on 2026-08-12, totaling $441,637, with holdings after sale of 542,171 shares.

02

Market read

This is primarily a sentiment datapoint from an insider sale, not a fundamental corporate event.

03

What to watch

The filing lacks context on taxes, diversification, or whether other holdings were adjusted; traders may over-weight the signal versus broader fundamentals.

Relevance 4/10Novelty 3/10Timing: after-hours filing on 2026-08-14

Background

The article is a SEC Form 4 insider transaction disclosure for Paysign, Inc. (PAYS).

Company-level read

Ticker impact

$PAYSNeutralMedium confidence
Context

Paysign CFO Baker Jeffery Bradford sold 35,000 shares in an open-market transaction valued at about $441,637, per Form 4 filed Aug. 14.

Expected impact

Likely limited, short-lived sentiment impact; no direct fundamental catalyst indicated.

Evidence & confidence

This is a routine Form 4 insider sale with no 10b5-1 plan and no accompanying company-specific news (earnings, guidance, contracts, or investigations) in the text.

Market effects

No sector read-through is provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

Insider sales are often planned for diversification or liquidity needs; without a 10b5-1 plan, the sale still may not imply negative company outlook.

Key entities

  • Paysign, Inc.

    Company whose CFO insider sale is disclosed via SEC Form 4.

  • Baker Jeffery Bradford

    Chief Financial Officer who sold 35,000 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PAYSMedAI 8/10

Paysign (PAYS) Q3 2026 Earnings Call Transcript

Paysign (PAYS) reported Q3 2026 earnings, highlighting growth in its patient affordability business with revenue doubling to $16.6M YoY. Plasma revenue rose 7.5% to $13.8M. The company expects to offset a loss of 113 plasma centers with new clients. Patient affordability drove strong margins and operating leverage, while Apherion, a plasma industry software, is under regulatory review.

$PAYSHigh

Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%

Paysign, Inc. (PAYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Earnings Release Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8% Patient Affordability Growth Drives Revenue and Margin Expansion Raises Full Year 2026 Gross Margin, Net Income, GAAP EPS and Adju

$PAYSHigh

Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook

Paysign, Inc. (PAYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Earnings Release Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook Growth Driven by Continued Momentum in Plasma and Patient Affordability Businesses Mix Shift and Expense Discipline Continue to Drive Gross and Oper